Medtronic
This article was originally published in The Gray Sheet
Executive Summary
Anticipates final FDA approval of its PCD pacer cardioverter- defibrillator in "approximately one month," Warren Watson, vice president of tachyarrhythmia marketing/business development at Medtronic, told attendees at the Piper Jaffray investment conference on Feb. 4. The firm received an approvable letter for the device last September.